Company Filing History:
Years Active: 2012-2015
Title: Frank Göhring: Innovator in CNS and Eye Disorders
Introduction
Frank Göhring is a notable inventor based in Würzburg, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of disorders affecting the central nervous system (CNS) and the eye. With a total of 2 patents, his work focuses on innovative methods and compositions that aim to improve patient outcomes.
Latest Patents
Göhring's latest patents include groundbreaking methods for the specific modulation of target genes in the CNS and the eye. These patents describe the use of compositions that contain compounds capable of modulating target genes or gene products. The pharmaceutical compositions are designed to treat disorders of the CNS and/or the eye, specifically targeting administration outside the blood-CNS and blood-retina barriers. Additionally, his patents provide methods for identifying nucleic acid molecules encoding polypeptides involved in CNS disorders, as well as methods for diagnosing these disorders. His work also includes the development of transgenic animals deficient in the expression of target genes, which can be crucial for research and drug discovery.
Career Highlights
Throughout his career, Frank Göhring has worked with prominent companies in the pharmaceutical industry. Notable among these are Acuity Pharmaceuticals, Inc. and Opko Pharmaceuticals, LLC. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical treatments.
Collaborations
Göhring has collaborated with several professionals, including Karina Drumm and Stefan Hubert Schlör. These partnerships have enhanced his research and development efforts, leading to innovative solutions for complex medical challenges.
Conclusion
Frank Göhring's contributions to the field of CNS and eye disorder treatments exemplify the impact of innovation in medicine. His patents and collaborations reflect a commitment to advancing healthcare through scientific discovery.